Todd Anderman

OCUL

Todd Anderman serves as officer: Chief Legal Officer at Ocular Therapeutix, Inc. (OCUL). This page tracks their complete SEC Form 4 insider trading history including stock purchases and sales.

Total Buys

0 trades

$0.00

Total Sells

2 trades

$224.7K

Net Position

Net Seller

$224.7K

Companies Traded

OCUL

Active Period

Oct 2025 – Oct 2026

2 total trades

Most Recent

Sell OCUL

Oct 13, 2026 · $87.4K

Todd Anderman's Insider Trading at Ocular Therapeutix, Inc. (OCUL)

Buys

0 · $0.00

Sells

2 · $224.7K

Total Shares Bought

Total Shares Sold

23,116

OCUL Price Chart

Loading chart...

Date	Type	Shares	Avg Price	Value	Shares After
Oct 13, 2026	Sell	11,984	$7.29	$87.4K	140,484
Oct 10, 2025	Sell	11,132	$12.34	$137.4K	87,568

Related Insiders

Jeffrey S. Heier

officer: Chief Scientific Officer

OCULSell · Oct 6, 2026

Peter Kaiser

officer: Chief Development Officer

OCULSell · Oct 6, 2026

Donald Notman

officer: Chief Operating Officer

OCULSell · Sep 2, 2026

Sanjay Nayak

officer: Chief Strategy Officer

OCULSell · Aug 26, 2026

Pravin Dugel

See Remarks

OCULSell · Aug 26, 2026

Nadia Waheed

officer: Chief Medical Officer

OCULSell · Jun 5, 2026

Namrata Saroj

Chief Business Officer

OCULSell · Nov 7, 2025

Explore More Insider Trading Data

OCUL Insider Trading Activity

View all insider trades at Ocular Therapeutix, Inc.

Healthcare Sector Insider Trades

See insider activity across healthcare stocks

Latest Insider Buys

Most recent insider purchases across all stocks

CEO Stock Purchases

Track CEO buying activity